Cell Therapy

Category

Seattle’s Infectious Disease Research Institute Upbeat by Initial Results of COVID-19 Study Investigating Immunotherapy

Seattle’s Infectious Disease Research Institute, a nonprofit organization, reports positive early results from a clinical trial centering on the use of immunotherapy on COVID-19 patients. According to the organization’s CEO, Dr. Corey Casper, the results are...

German Government Injects €2.45m to ‘Get to Root of Problem’ of Leukemia: Preliminary Stem Cell-based Research

The German Federal Ministry of Education and Research (BMBF), has transferred €2.45m to a research collaborative known as LeukoSyStem to “get to the root of the problem” of leukemia. With an emphasis on stem cell research and “the starting point of leukemia,” the...

Elite Research Centers Ink Deal with Lonza to Evaluate (Pilot) Cell Therapy Manufacturing for Next Generation Treatments

In a notable partnership, Switzerland-based Lonza inked a partnership with leading research institutes and academic medical centers including Stanford University School of Medicine, Fred Hutchinson Cancer Research Center and Parker Institute for Cancer Immunotherapy...

CSL Behring & University City Science Center Accelerate Research for New Biotherapies with Grant Awards

University of Pittsburgh and University of Delaware researchers received funding for research covering innovative therapies targeting pulmonary fibrosis (FB) to Gene delivery to or editing Hematopoietic (blood) Stem and Progenitor Cells (HSPCs). Two clinical...